US Stock MarketDetailed Quotes

AURA Aura Biosciences

Watchlist
  • 7.590
  • +0.200+2.71%
Close Aug 23 16:00 ET
  • 7.590
  • 0.0000.00%
Post 16:02 ET
376.51MMarket Cap-4240P/E (TTM)

Aura Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-10.13%-16.13M
-48.99%-24.45M
-16.93%-63.85M
3.48%-17.39M
-43.15%-15.4M
-37.80%-14.65M
-7.97%-16.41M
-68.47%-54.6M
-49.04%-18.01M
-23.82%-10.76M
Net income from continuing operations
-11.14%-20.34M
-12.82%-19.71M
-30.03%-76.41M
-33.65%-22.13M
-16.42%-18.51M
-35.87%-18.3M
-36.08%-17.47M
-66.70%-58.76M
-42.33%-16.56M
-79.92%-15.9M
Operating gains losses
----
----
1,045.45%208K
-30.07%207K
----
----
----
-833.33%-22K
4,833.33%296K
----
Depreciation and amortization
4.33%313K
-6.71%306K
10.03%1.3M
0.31%324K
13.58%343K
1.35%300K
28.13%328K
41.64%1.18M
40.43%323K
39.81%302K
Other non cash items
6.51%360K
5.14%348K
89.77%1.84M
98.06%715K
42.01%453K
39.67%338K
619.57%331K
6,353.33%968K
2,908.33%361K
7,875.00%319K
Change In working capital
-18.36%1.73M
-1,223.54%-6.8M
215.47%4.44M
150.60%2.03M
-75.34%808K
84.06%2.11M
87.91%-514K
-1,120.95%-3.85M
-101.30%-4.02M
672.90%3.28M
-Change in prepaid assets
-27.49%1.2M
-263.61%-3.75M
210.02%3.58M
114.19%520K
-167.61%-881K
114.58%1.65M
238.07%2.29M
9.01%-3.25M
-21.77%-3.66M
235.45%1.3M
-Change in payables and accrued expense
5.35%807K
-20.32%-2.87M
295.47%2.27M
521.77%1.97M
-11.76%1.92M
13.99%766K
7.87%-2.39M
-82.39%574K
-68.68%317K
457.95%2.18M
-Change in other current assets
111.69%9K
128.00%56K
79.67%-86K
141.61%176K
--15K
---77K
---200K
---423K
---423K
--0
-Change in other current liabilities
-27.68%-286K
-8.22%-237K
-77.69%-1.32M
-153.20%-633K
-21.78%-246K
---224K
---219K
---744K
---250K
---202K
Cash from discontinued investing activities
Operating cash flow
-10.13%-16.13M
-48.99%-24.45M
-16.93%-63.85M
3.48%-17.39M
-43.15%-15.4M
-37.80%-14.65M
-7.97%-16.41M
-68.47%-54.6M
-49.04%-18.01M
-23.82%-10.76M
Investing cash flow
Cash flow from continuing investing activities
-7.32%19.84M
114.05%9.4M
-67.92%-113.96M
-434.01%-90.12M
20.52%21.63M
149.28%21.41M
-162.29%-66.88M
-3,093.84%-67.87M
-1,960.56%-16.88M
3,231.94%17.95M
Net PPE purchase and sale
-172.02%-525K
19.27%-88K
35.19%-709K
11.45%-317K
-42.86%-90K
-160.81%-193K
81.80%-109K
48.52%-1.09M
56.29%-358K
89.01%-63K
Net investment purchase and sale
-5.71%20.37M
114.20%9.48M
-69.61%-113.25M
-443.67%-89.8M
20.60%21.72M
149.81%21.6M
-168.16%-66.77M
---66.78M
---16.52M
--18.01M
Cash from discontinued investing activities
Investing cash flow
-7.32%19.84M
114.05%9.4M
-67.92%-113.96M
-434.01%-90.12M
20.52%21.63M
149.28%21.41M
-162.29%-66.88M
-3,093.84%-67.87M
-1,960.56%-16.88M
3,231.94%17.95M
Financing cash flow
Cash flow from continuing financing activities
-96.65%83K
25.87%253K
1.74%97.29M
-2.33%92.99M
1,463.46%1.63M
701.94%2.48M
1,082.35%201K
-42.48%95.63M
18.79%95.2M
109.32%104K
Net common stock issuance
----
----
-62.92%3.17M
--0
--1.35M
----
----
-89.14%8.55M
--8.55M
--0
Net preferred stock issuance
----
----
6.89%92.62M
----
----
----
----
-0.66%86.65M
----
----
Proceeds from stock option exercised by employees
-87.42%83K
25.87%253K
249.77%1.5M
--369K
163.46%274K
113.59%660K
1,082.35%201K
23.21%430K
--0
420.00%104K
Cash from discontinued financing activities
Financing cash flow
-96.65%83K
25.87%253K
1.74%97.29M
-2.33%92.99M
1,463.46%1.63M
701.94%2.48M
1,082.35%201K
-42.48%95.63M
18.79%95.2M
109.32%104K
Net cash flow
Beginning cash position
-31.14%27.05M
-65.80%41.85M
-17.99%122.37M
-9.17%56.37M
-11.41%48.52M
-63.81%39.28M
-17.99%122.37M
753.27%149.21M
-24.29%62.06M
-40.69%54.77M
Current changes in cash
-58.92%3.8M
82.18%-14.8M
-199.99%-80.52M
-124.08%-14.52M
7.71%7.85M
117.19%9.24M
-104.25%-83.09M
-120.38%-26.84M
-10.30%60.31M
170.24%7.29M
End cash Position
-36.43%30.84M
-31.14%27.05M
-65.80%41.85M
-65.80%41.85M
-9.17%56.37M
-11.41%48.52M
-63.81%39.28M
-17.99%122.37M
-17.99%122.37M
-24.29%62.06M
Free cash flow
-12.23%-16.65M
-48.54%-24.54M
-15.91%-64.56M
3.63%-17.7M
-43.15%-15.49M
-38.65%-14.84M
-4.57%-16.52M
-61.27%-55.7M
-42.36%-18.37M
-16.84%-10.82M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -10.13%-16.13M-48.99%-24.45M-16.93%-63.85M3.48%-17.39M-43.15%-15.4M-37.80%-14.65M-7.97%-16.41M-68.47%-54.6M-49.04%-18.01M-23.82%-10.76M
Net income from continuing operations -11.14%-20.34M-12.82%-19.71M-30.03%-76.41M-33.65%-22.13M-16.42%-18.51M-35.87%-18.3M-36.08%-17.47M-66.70%-58.76M-42.33%-16.56M-79.92%-15.9M
Operating gains losses --------1,045.45%208K-30.07%207K-------------833.33%-22K4,833.33%296K----
Depreciation and amortization 4.33%313K-6.71%306K10.03%1.3M0.31%324K13.58%343K1.35%300K28.13%328K41.64%1.18M40.43%323K39.81%302K
Other non cash items 6.51%360K5.14%348K89.77%1.84M98.06%715K42.01%453K39.67%338K619.57%331K6,353.33%968K2,908.33%361K7,875.00%319K
Change In working capital -18.36%1.73M-1,223.54%-6.8M215.47%4.44M150.60%2.03M-75.34%808K84.06%2.11M87.91%-514K-1,120.95%-3.85M-101.30%-4.02M672.90%3.28M
-Change in prepaid assets -27.49%1.2M-263.61%-3.75M210.02%3.58M114.19%520K-167.61%-881K114.58%1.65M238.07%2.29M9.01%-3.25M-21.77%-3.66M235.45%1.3M
-Change in payables and accrued expense 5.35%807K-20.32%-2.87M295.47%2.27M521.77%1.97M-11.76%1.92M13.99%766K7.87%-2.39M-82.39%574K-68.68%317K457.95%2.18M
-Change in other current assets 111.69%9K128.00%56K79.67%-86K141.61%176K--15K---77K---200K---423K---423K--0
-Change in other current liabilities -27.68%-286K-8.22%-237K-77.69%-1.32M-153.20%-633K-21.78%-246K---224K---219K---744K---250K---202K
Cash from discontinued investing activities
Operating cash flow -10.13%-16.13M-48.99%-24.45M-16.93%-63.85M3.48%-17.39M-43.15%-15.4M-37.80%-14.65M-7.97%-16.41M-68.47%-54.6M-49.04%-18.01M-23.82%-10.76M
Investing cash flow
Cash flow from continuing investing activities -7.32%19.84M114.05%9.4M-67.92%-113.96M-434.01%-90.12M20.52%21.63M149.28%21.41M-162.29%-66.88M-3,093.84%-67.87M-1,960.56%-16.88M3,231.94%17.95M
Net PPE purchase and sale -172.02%-525K19.27%-88K35.19%-709K11.45%-317K-42.86%-90K-160.81%-193K81.80%-109K48.52%-1.09M56.29%-358K89.01%-63K
Net investment purchase and sale -5.71%20.37M114.20%9.48M-69.61%-113.25M-443.67%-89.8M20.60%21.72M149.81%21.6M-168.16%-66.77M---66.78M---16.52M--18.01M
Cash from discontinued investing activities
Investing cash flow -7.32%19.84M114.05%9.4M-67.92%-113.96M-434.01%-90.12M20.52%21.63M149.28%21.41M-162.29%-66.88M-3,093.84%-67.87M-1,960.56%-16.88M3,231.94%17.95M
Financing cash flow
Cash flow from continuing financing activities -96.65%83K25.87%253K1.74%97.29M-2.33%92.99M1,463.46%1.63M701.94%2.48M1,082.35%201K-42.48%95.63M18.79%95.2M109.32%104K
Net common stock issuance ---------62.92%3.17M--0--1.35M---------89.14%8.55M--8.55M--0
Net preferred stock issuance --------6.89%92.62M-----------------0.66%86.65M--------
Proceeds from stock option exercised by employees -87.42%83K25.87%253K249.77%1.5M--369K163.46%274K113.59%660K1,082.35%201K23.21%430K--0420.00%104K
Cash from discontinued financing activities
Financing cash flow -96.65%83K25.87%253K1.74%97.29M-2.33%92.99M1,463.46%1.63M701.94%2.48M1,082.35%201K-42.48%95.63M18.79%95.2M109.32%104K
Net cash flow
Beginning cash position -31.14%27.05M-65.80%41.85M-17.99%122.37M-9.17%56.37M-11.41%48.52M-63.81%39.28M-17.99%122.37M753.27%149.21M-24.29%62.06M-40.69%54.77M
Current changes in cash -58.92%3.8M82.18%-14.8M-199.99%-80.52M-124.08%-14.52M7.71%7.85M117.19%9.24M-104.25%-83.09M-120.38%-26.84M-10.30%60.31M170.24%7.29M
End cash Position -36.43%30.84M-31.14%27.05M-65.80%41.85M-65.80%41.85M-9.17%56.37M-11.41%48.52M-63.81%39.28M-17.99%122.37M-17.99%122.37M-24.29%62.06M
Free cash flow -12.23%-16.65M-48.54%-24.54M-15.91%-64.56M3.63%-17.7M-43.15%-15.49M-38.65%-14.84M-4.57%-16.52M-61.27%-55.7M-42.36%-18.37M-16.84%-10.82M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg